Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology

<div>The regulatory function of microRNAs/peroxisome proliferator-activated receptors (PPARs) axis in cardiomyocyte apoptosis, and cardiac remodeling and dysfunction.<i> CKD: chronic kidney disease; TGF-<i>β</i>1: transforming growth factor <i>β</i>1; I/R: ischemia/reperfusion; Akt: serine/threonine kinase 1; Mcl-1: myeloid leukaemia cell differentiation protein-1; Mcl-2: an anti-apoptotic Bcl-2 family member; MEF2D: myocyte enhancer factor 2D. CM: cardiac myxoma.</i></div>

PPAR Research

fig3

Figure 3

Figure 3: Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology 

Figure 3 | Crosstalk between MicroRNAs and Peroxisome Proliferator-Activated Receptors and Their Emerging Regulatory Roles in Cardiovascular Pathophysiology 